AMLOBLAZE AT

Introduction

AMLOBLAZE AT is a prescription medicine containing Amlodipine 5 mg and Atenolol 50 mg, a scientifically established combination of a calcium channel blocker and a cardioselective beta-blocker. This dual-action therapy is widely prescribed for the management of hypertension (high blood pressure) and chronic stable angina, particularly in patients who require more than one antihypertensive agent to achieve optimal blood pressure control.

The two active ingredients in AMLOBLAZE AT work through complementary mechanisms. Amlodipine relaxes and widens blood vessels, improving blood flow and reducing peripheral vascular resistance, while Atenolol decreases heart rate and myocardial contractility, reducing cardiac workload and oxygen demand. Together, they provide effective blood pressure reduction and improved cardiovascular protection.

Long-term control of hypertension with medicines such as AMLOBLAZE AT, when combined with healthy lifestyle modifications, has been shown to reduce the risk of cardiovascular complications including stroke, myocardial infarction, heart failure, and kidney disease associated with persistently elevated blood pressure.

Uses of AMLOBLAZE AT

AMLOBLAZE AT is indicated for the treatment of cardiovascular conditions where combination therapy is considered appropriate by a healthcare professional.

It may be prescribed for:

1. Hypertension (high blood pressure)
2. Chronic stable angina (chest pain due to coronary artery disease)
3. Patients whose blood pressure is inadequately controlled with a single antihypertensive medicine
4. Reduction of cardiovascular risk associated with sustained hypertension as part of comprehensive cardiovascular management
5. Long-term blood pressure maintenance in appropriate patients

Treatment should always be individualized based on the patient's clinical condition, cardiovascular risk profile, and current treatment guidelines.

Benefits of AMLOBLAZE AT

AMLOBLAZE AT combines two well-established antihypertensive agents Amlodipine and Atenolol with complementary mechanisms of action, providing effective blood pressure control and anti-anginal benefits.

Scientific benefits include:

1. Effectively lowers systolic and diastolic blood pressure through dual pharmacological mechanisms.
2. Combines peripheral vasodilation with heart rate reduction for comprehensive cardiovascular management.
3. Helps reduce myocardial oxygen demand, thereby improving symptoms of chronic stable angina.
4. Supports sustained 24-hour blood pressure control with once-daily administration.
5. May improve treatment adherence by combining two antihypertensive medicines into a single tablet.
6. Long-term blood pressure control has been associated with a lower risk of stroke, myocardial infarction, heart failure, and chronic kidney disease.
7. Provides effective therapy for patients requiring combination treatment to achieve guideline-recommended blood pressure targets.
8. The complementary actions of Amlodipine and Atenolol help minimize compensatory increases in heart rate that may occur with vasodilator therapy alone.

How AMLOBLAZE AT Works

AMLOBLAZE AT works through the complementary actions of its two active ingredients.

Amlodipine is a long-acting dihydropyridine calcium channel blocker that inhibits calcium influx into vascular smooth muscle cells. This causes relaxation of arterial blood vessels, reduces peripheral vascular resistance, and lowers blood pressure while improving blood flow.

Atenolol is a selective beta₁-adrenergic receptor blocker that slows the heart rate, reduces the force of cardiac contraction, and decreases cardiac output. These effects reduce myocardial oxygen demand and help control blood pressure while improving symptoms of chronic stable angina.

By combining these two mechanisms, AMLOBLAZE AT provides effective blood pressure reduction while reducing cardiac workload. This combination contributes to improved cardiovascular outcomes when used as part of a comprehensive treatment plan that includes lifestyle modification and regular medical follow-up.

Dosage & Administration

AMLOBLAZE AT should be taken only under the supervision of a qualified healthcare professional.

General Adult Dosage

1. The usual dosage is one tablet once daily, or as directed by the treating physician.
2. The tablet may be taken with or without food, preferably at the same time each day.
3. Dosage should be individualized based on blood pressure response, heart rate, and overall clinical condition.
4. Patients should continue lifestyle measures including a low-sodium diet, regular physical activity, weight management, smoking cessation, and moderation of alcohol intake alongside pharmacological therapy.
5. Patients should not discontinue AMLOBLAZE AT abruptly, particularly because sudden withdrawal of beta-blocker therapy may worsen angina or precipitate cardiovascular events in susceptible individuals. Any discontinuation should be guided by a healthcare professional.

Possible Side Effects

Like all medicines, AMLOBLAZE AT may cause side effects, although many patients tolerate treatment well.

The more commonly reported side effects include:

1. Dizziness
2. Headache
3. Fatigue
4. Swelling of the ankles or feet (peripheral edema)
5. Slow heart rate (bradycardia)
6. Flushing
7. Nausea
8. Cold hands or feet
9. Mild gastrointestinal discomfort

Patients should contact their healthcare provider if they experience persistent dizziness, fainting, marked slowing of the heart rate, worsening chest pain, difficulty breathing, severe swelling, or signs of an allergic reaction.

Contraindications & Precautions

AMLOBLAZE AT should not be used in patients with:

1. Known hypersensitivity to Amlodipine, Atenolol, other dihydropyridine calcium channel blockers, or any component of the formulation.
2. Severe bradycardia (markedly slow heart rate).
3. Second- or third-degree atrioventricular (AV) block without a functioning pacemaker.
4. Cardiogenic shock.
5. Sick sinus syndrome (unless a permanent pacemaker is present).
6. Uncontrolled or decompensated heart failure.
7. Severe hypotension.
8. Severe peripheral arterial circulatory disorders, where beta-blocker therapy may worsen symptoms.

Important Precautions

AMLOBLAZE AT should be used with caution in patients with:

1. Diabetes mellitus, as beta-blockers may mask symptoms of hypoglycemia.
2. Bronchospastic disorders such as asthma or chronic obstructive pulmonary disease (COPD), where cardioselective beta-blockers should be used cautiously.
3. Peripheral vascular disease.
4. Hepatic impairment (Amlodipine exposure may be increased).
5. Renal impairment (Atenolol is primarily eliminated by the kidneys and dose adjustment may be required).
6. Elderly patients, who may require careful dose titration and monitoring.

Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, and herbal supplements they are taking, as certain medications may interact with either Amlodipine or Atenolol.

Regular monitoring of blood pressure, heart rate, and overall cardiovascular status helps ensure the safe and effective use of AMLOBLAZE AT.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. AMLOBLAZE AT is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, monitoring, and duration of therapy. Clinical decisions should be individualized based on the patient's medical history, associated medical conditions, and current evidence-based treatment guidelines.